Delayed MS Decision and Trial Miss Add to Sanofi's R&D Challenges [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
Sanofi (NASDAQ:SNY) said on December 15 that a US regulatory decision for its experimental multiple sclerosis drug will be delayed again. On the same day, the company also disclosed weaker-than-expected results from a late-stage clinical study, adding to a difficult stretch for its research pipeline. Analysts said the latest setbacks could weigh on confidence in Sanofi (NASDAQ:SNY)'s future drug portfolio. Earlier this year, the company reported weak results from experimental treatments for eczema and smokers' lungs. That track record has increased pressure on management to find new growth drivers beyond its blockbuster asthma drug Dupixent. Sanofi said the US Food and Drug Administration decision on tolebrutinib, which is being reviewed for non-relapsing secondary progressive multiple sclerosis, will now come after the December 28 action date. That marks a second delay, after the decision was initially expected in September. The company said it expects additional guidance from t
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA [Yahoo! Finance]Yahoo! Finance
- Sanofi Agrees to Buy Dynavax for $2.2 Billion After FDA MS Drug Rejection [Yahoo! Finance]Yahoo! Finance
- Honoring 45 Organ, Eye and Tissue Donors, Living Donors and Recipients: The 2026 OneLegacy Donate Life Rose Parade® Float Celebrates 23 Years of Participation in the Iconic Rose Parade® [Yahoo! Finance]Yahoo! Finance
- Sanofi to Buy Dynavax to Boost Vaccines Business [Yahoo! Finance]Yahoo! Finance
- What Sanofi Is Getting Through The Acquisition Of Dynavax [Seeking Alpha]Seeking Alpha
SNY
Sec Filings
- 12/29/25 - Form 6-K
- 12/29/25 - Form 6-K
- 12/23/25 - Form 6-K
- SNY's page on the SEC website